Back to Reference Library
veterinary
behaviour
farriery
2009
Case Report

Normal function of the hypothalamic-pituitary growth axis in three dwarf Friesian foals.

Authors: de Graaf-Roelfsema E, Back W, Keizer H A, Stout T A E, van der Kolk J H

Journal: The Veterinary record

Summary

# Editorial Summary This 2009 study investigated whether dwarfism in three Friesian foals resulted from dysfunction of the growth hormone (GH) axis—a common cause of growth retardation in equines. The researchers collected serial blood samples to profile endogenous GH secretion, and in one foal they directly tested pituitary responsiveness to GH-releasing hormone stimulation and the ability of exogenous recombinant equine GH to drive insulin-like growth factor-1 (IGF-1) production. All three dwarf foals demonstrated normal baseline GH secretion and appropriate GH responses to pharmacological stimulation (a 1400% increase following GHRH administration), whilst exogenous GH treatment doubled serum IGF-1 concentrations as expected in healthy animals; moreover, resting IGF-1 levels in the dwarf foals were indistinguishable from age-matched normal counterparts. These findings suggest that Friesian dwarfism in this cohort was not attributable to defects in the hypothalamic-pituitary-somatotropic axis itself, pointing instead towards potential skeletal responsiveness problems, genetic dysplasias, or other downstream mechanisms affecting bone development. For practitioners managing dwarf foals, these results imply that growth hormone axis dysfunction should not be assumed as a causal mechanism without further investigation, and that the aetiology of dwarfism in individual cases likely involves factors beyond simple endocrine insufficiency.

Read the full abstract on PubMed

Practical Takeaways

  • Dwarfism in Friesian foals does not appear to result from defective growth hormone secretion or IGF-1 axis dysfunction, suggesting other genetic or developmental mechanisms underlie the condition
  • These dwarf foals demonstrate normal responsiveness to GH-releasing hormone and exogenous recombinant GH, indicating the GH-IGF-1 axis is structurally intact despite the dwarfing phenotype
  • Assessment of growth disorders in dwarf foals should consider mechanisms beyond simple GH or IGF-1 deficiency

Key Findings

  • All three dwarf Friesian foals secreted endogenous growth hormone, indicating functional GH production
  • GHRH stimulation produced a 1400% increase in plasma GH concentration in the tested dwarf foal
  • Recombinant equine GH treatment (20 microg/kg daily for 10 days) resulted in a 100% increase in serum IGF-1 concentration
  • Basal serum IGF-1 concentrations in dwarf foals were not significantly different from age-matched normal foals

Conditions Studied

dwarfism in friesian foalsgrowth hormone deficiency assessmenthypothalamic-pituitary-growth axis function